Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: Disappearance after rituximab therapy does not predict clinical response

Blood

Volumn 96, Issue 13, 2000, Pages 4055-4063

  Yang, Jie ^b   Tao, Qian ^b   Flinn, Ian W ^b   Murray, Paul G ^b   Post, Linda E ^b   Ma, Hong ^b   Piantadosi, Steven ^b   Caligiuri, Michael A ^b   Ambinder, Richard F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; RITUXIMAB; VIRUS DNA;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD; CANCER STEM CELL; CHILD; COMPARATIVE STUDY; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISOLATION AND PURIFICATION; LYMPHOCYTE TRANSFUSION; LYMPHOPROLIFERATIVE DISEASE; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PASSIVE IMMUNIZATION; PATHOLOGY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSPLANTATION; TREATMENT OUTCOME; VIREMIA; VIROLOGY; VIRUS ACTIVATION; VIRUS GENOME; VIRUS INFECTION; VIRUS LOAD;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTE SUBSETS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOSUPPRESSION; LYMPHOCYTE TRANSFUSION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION; TREATMENT OUTCOME; TUMOR STEM CELLS; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIREMIA; VIRUS ACTIVATION;

EID: 0034672367     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.13.4055.h8004055_4055_4063     Document Type: Article

References (22)

1. Ambinder RF, Lemas MV, Moore S, Yang J, Fabian D, Krone C. Epstein-Barr virus and lymphoma. Cancer Treat Res. 1999;99:27.
2. Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res. 1990;55:133.
3. Anagnostopoulos I, Herbst H, Niedobitek G, Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood. 1989;74:810.
4. Weiss LM. Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med. 1989:320:502.
5. Yao QY, Rickinson AB, Epstein MA. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer. 1985:35:35.
6. Miyashita EM, Yang B, Lam KM, Crawford DH, Thorley-Lawson DA. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell. 1995; 80:593.
7. Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol. 1997;71:4882.
8. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity. 1998:9:395.
9. Tierney RJ, Steven N, Young LS, Rickinson AB. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol. 1994:68:7374.
10. Qu L, Rowe DT: Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol. 1992:66:3715.
11. Chen F, Zou JZ, di Renzo L, et al. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol. 1995:69:3752.
12. Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 3rd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1996:2397.
13. Young L, Alfieri C, Hennessy K, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med. 1989:321:1080.
14. Rowe DT, Qu L, Reyes J, et al. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol. 1997;35:1612.
15. Green M, Cacciarelli TV, Mazariegos GV, et al. Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation. 1998; 66:1641.
16. Riddler SA, Breinig MC, McKnight JL. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood. 1994;84:972.
17. Kenagy DN, Schlesinger Y, Weck K, Ritter JH, Gaudreault-Keener MM, Storch GA. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation. 1995:60:547.
18. Lucas KG, Burton RL, Zimmerman SE, et al. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood. 1998:91:3654.
19. Lawrence JB, Villnave CA, Singer RH. Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell. 1988;52:51.
20. Lin JC, Lin SC, De BK, Chan WP, Evatt BL. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Blood. 1993:81:3372.
21. Decker LL, Klaman LD, Thorley-Lawson DA. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J Virol. 1996;70:3286.
22. Kebelmann-Betzing C, Seeger K, Dragon S, et al. Advantages of a new Taq DNA polymerase in multiplex PCR and time-release PCR. Biotechniques. 1998;24:154.